WO2014143994A3 - Methods and compositions for evaluating genetic markers - Google Patents

Methods and compositions for evaluating genetic markers Download PDF

Info

Publication number
WO2014143994A3
WO2014143994A3 PCT/US2014/028212 US2014028212W WO2014143994A3 WO 2014143994 A3 WO2014143994 A3 WO 2014143994A3 US 2014028212 W US2014028212 W US 2014028212W WO 2014143994 A3 WO2014143994 A3 WO 2014143994A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
genetic markers
evaluating genetic
genetic loci
Prior art date
Application number
PCT/US2014/028212
Other languages
French (fr)
Other versions
WO2014143994A2 (en
Inventor
Gregory Porreca
Mark UMBARGER
Original Assignee
Good Start Genetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/934,093 external-priority patent/US20130337447A1/en
Application filed by Good Start Genetics, Inc. filed Critical Good Start Genetics, Inc.
Priority to CA2907177A priority Critical patent/CA2907177A1/en
Priority to EP14762322.7A priority patent/EP2971114A4/en
Publication of WO2014143994A2 publication Critical patent/WO2014143994A2/en
Publication of WO2014143994A3 publication Critical patent/WO2014143994A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Aspects of the invention relates to methods and compositions that are useful to reduce bias and increase the reproducibility of multiplex analysis of genetic loci. In some configurations, predetermined preparative steps and/or nucleic acid sequence analysis techniques are used in multiplex analyses for a plurality of genetic loci in a plurality of samples.
PCT/US2014/028212 2013-03-15 2014-03-14 Methods and compositions for evaluating genetic markers WO2014143994A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2907177A CA2907177A1 (en) 2013-03-15 2014-03-14 Methods and compositions for evaluating genetic markers
EP14762322.7A EP2971114A4 (en) 2013-03-15 2014-03-14 Methods and compositions for evaluating genetic markers

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361789164P 2013-03-15 2013-03-15
US61/789,164 2013-03-15
US13/934,093 2013-07-02
US13/934,093 US20130337447A1 (en) 2009-04-30 2013-07-02 Methods and compositions for evaluating genetic markers

Publications (2)

Publication Number Publication Date
WO2014143994A2 WO2014143994A2 (en) 2014-09-18
WO2014143994A3 true WO2014143994A3 (en) 2015-02-19

Family

ID=51538293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/028212 WO2014143994A2 (en) 2013-03-15 2014-03-14 Methods and compositions for evaluating genetic markers

Country Status (3)

Country Link
EP (1) EP2971114A4 (en)
CA (1) CA2907177A1 (en)
WO (1) WO2014143994A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3055338B1 (en) * 2016-09-01 2020-05-29 Centre National De La Recherche Scientifique METHOD FOR IN VITRO DETECTION AND IDENTIFICATION OF ONE OR MORE MICROORGANISMS INVOLVED IN THE DEGRADATION, MODIFICATION OR SEQUENCING PROCESS OF ONE OR MORE CONTAMINANTS PRESENT IN A BIOLOGICAL SAMPLE
CN112029841B (en) * 2019-06-03 2024-02-09 香港中文大学 Method for quantifying telomere length and genomic motifs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070162983A1 (en) * 2003-11-19 2007-07-12 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
WO2010126614A2 (en) * 2009-04-30 2010-11-04 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
US20120165202A1 (en) * 2009-04-30 2012-06-28 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2888779A1 (en) * 2012-11-07 2014-05-15 Good Start Genetics, Inc. Validation of genetic tests

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070162983A1 (en) * 2003-11-19 2007-07-12 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
WO2010126614A2 (en) * 2009-04-30 2010-11-04 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
US20120165202A1 (en) * 2009-04-30 2012-06-28 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP2971114A4 *
THIYAGARAJAN, S ET AL., PATHOGENMIPER: A TOOL FOR THE DESIGN OF MOLECULAR INVERSION PROBES TO DETECT MULTIPLE PATHOGENS., 14 November 2006 (2006-11-14), pages PAGE 2 , PAGE 3, XP021021640 *

Also Published As

Publication number Publication date
EP2971114A4 (en) 2016-11-23
CA2907177A1 (en) 2014-09-18
EP2971114A2 (en) 2016-01-20
WO2014143994A2 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
WO2010126614A3 (en) Methods and compositions for evaluating genetic markers
HK1250757A1 (en) Nucleic acid sequence analysis from single cells
EP3452591A4 (en) Macromolecule analysis employing nucleic acid encoding
HK1217971A1 (en) Methods, compositions, and kits for nucleic acid analysis
DK3901281T3 (en) SPATIALLY SEPARATE, MULTIPLEX NUCLEIC ACID ANALYSIS OF BIOLOGICAL SAMPLES
DK3565905T3 (en) NUCLEIC ACID SEQUENCE USING AFFINITY REAGENTS
WO2016130704A3 (en) Methods and compositions for analyzing cellular components
EP4026905C0 (en) Methods for barcoding nucleic acid molecules from individual cells or cell populations
DK3325669T3 (en) Compositions and methods for RNA analysis
WO2014145820A3 (en) Multiple tagging of long dna fragments
EP3169793A4 (en) Isothermal methods for amplifying nucleic acid samples
EA201892489A1 (en) NUMBER OF TARGETS FOR MULTIPLEX OPTIMIZED AMPLIFICATION WITH NON-CONFORMITY (MOMA)
WO2014144822A3 (en) Methods and compositions for tagging and analyzing samples
EP3389481A4 (en) Methods, compositions, kits and devices for rapid analysis of biological markers
EA201792389A1 (en) REAL-TIME PCR FOR MULTIPLEX OPTIMIZED AMPLIFICATION WITH NON-CORRESPONDENCE (MOMA) AND FOR ASSESSMENT OF NUCLEAR DNA
WO2015195949A3 (en) Methods, compositions, and devices for rapid analysis of biological markers
EP3559231A4 (en) Methods for processing nucleic acid samples
EP3480310A4 (en) Probe for nucleic acid enrichment and capture, and design method thereof
EP3090058A4 (en) Systems, compositions and methods for detecting and analyzing micro-rna profiles from a biological sample
EP3201350A4 (en) Method for nucleic acid analysis directly from an unpurified biological sample
DK3152316T3 (en) Sample preparation for nucleic acid amplification
MX2017001405A (en) Detection of target nucleic acids using hybridization.
DK3538891T3 (en) COMPOSITIONS AND PROCEDURES FOR CONTEMPORARY GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC ANALYSIS OF SINGLE CELLS
WO2014005125A3 (en) Fluorescent compounds and uses thereof
WO2017044993A3 (en) Nucleic acid analysis by joining barcoded polynucleotide probes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14762322

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2907177

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2014762322

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014762322

Country of ref document: EP